Stereotaxis, Inc. (AMEX: STXS) is a Healthcare company (Medical - Instruments & Supplies) with a market capitalization of $88M. The Maz Rating grades it against the other companies in its sector.
Stereotaxis, Inc.'s current Maz Rating and its five factor grades are for members: log in to see them.
At $0.88, Stereotaxis, Inc. trades at 2.7x sales and 4.0x book value. Over the last twelve months it generated about $33M of revenue and a net loss of $26M. It runs a gross margin of 52.5%, an operating margin of -69.4% and a net margin of -70.9%. It shows return on equity of -115.8%, return on invested capital of -42.3% and a free cash flow yield of -17.5%. On the balance sheet: a debt-to-equity ratio of 0.37 and a current ratio of 1.08. Over the past 52 weeks the share price ranged from $0.80 to $2.86, with a beta of 1.40.
Stereotaxis, Inc. does not currently pay a dividend.
12 Wall Street analyst ratings cover the stock: 12 Buy, for a Buy consensus. This is the sell side's view, separate from the Maz Rating.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.